KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

BACKGROUND AND AIMS: Increased expression of Chromosome Region Maintenance (CRM-1)/exportin-1 (XPO-1) has been correlated with poor prognosis in several aggressive tumors, making it an interesting therapeutic target. Selective Inhibitor of Nuclear Export (SINE) compounds bind to XPO-1 and block its...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Gravina, Giovanni Luca, Mancini, Andrea, Sanita, Patrizia, Vitale, Flora, Marampon, Francesco, Ventura, Luca, Landesman, Yosef, McCauley, Dilara, Kauffman, Michael, Shacham, Sharon, Festuccia, Claudio
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4666032/
https://ncbi.nlm.nih.gov/pubmed/26620414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1936-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi